Exponent Inc (EXPO) Q3 2026 Earnings Call Highlights: Double-Digit Revenue Growth
Exponent Inc (EXPO) reported Q3 2026 revenue growth of 12%, with Engineering up 13% but Environmental Health at 3%. Q4 growth is guided to 8-10%. Interest income fell to $668K, and the tax rate rose to 28%. AI-related work now represents 15-20% of business. A large project, 4% of Q2 revenue, is winding down. The company continues share buybacks and hiring for growth areas.
How this was made
The 30-second read
Why it matters
Traders should focus on whether the large-project wind-down and Environmental Health lag are temporary (ramp and comparable effects) or signal broader demand softness, using the explicit Q4 growth guide and utilization guidance as anchors.
Market read
The call provides actionable Q4 growth guidance (8% to 10%) plus quantified headwinds (large project share falling below 1% in Q4) against strong utilization (76.7% in Q3).
What to watch
Environmental Health’s 3% growth is tied to ramping senior hires and PFAS/regulatory capability building, so near-term segment weakness could reverse as recruiting ramps and projects shift.
Background
Exponent’s Q3 call highlights utilization strength, an AI work mix estimate, segment performance divergence, and a large project shrinking as it winds down.
Ticker impact
Exponent guided Q4 net revenue growth to 8% to 10% and discussed utilization, AI contribution, and a large-project revenue wind-down.
Likely mixed reaction, with support from strong utilization and demand commentary offset by the guided growth moderation and Environmental Health lag.
The article contains explicit Q4 guidance (8% to 10% growth), segment divergence (Environmental Health 3% vs Engineering 13%), and a quantified large-project share decline (4% to 2.5%, winding to under 1%).
Market effects
Provides read-through on demand strength and AI-related work mix for scientific/engineering services, but no direct sector-wide catalyst.
No clear regional macro linkage beyond general risk appetite for small-cap growth earnings.
Limited global relevance; story is company-specific with no cross-border policy or supply shock.
Counterpoint
The Q4 growth moderation may be largely a tough comparable and utilization normalization, not a true demand slowdown, given management said demand is not moderating.
Key entities
- companyExponent Inc
Scientific and engineering services firm providing Q3 highlights and Q4 net revenue growth guidance.
- executiveCatherine Corrigan
CEO discussing segment recruiting priorities and AI work ramp areas.
- executiveEric Anderson
CFO discussing utilization, demand, guidance drivers, and capital allocation.
- executiveJohn Pye
Group VP discussing AI stack growth and reactive AI work visibility in disputes.
